NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Clinical trials for NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) explained in plain language.
Never miss a new study
Get alerted when new NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear
Sign up with your email to follow new studies for NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancers? XL092 combo enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called XL092, alone or with other immune-boosting drugs, in people with advanced solid tumors (like kidney, prostate, lung, or colon cancer) that can't be removed by surgery. The main goals are to find safe doses and see if the treatment sh…
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated May 16, 2026 23:51 UTC
-
New drug trial hopes to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early-stage study tests a new drug called KO-2806 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and see if the drug can shrink tumors, either alone or combined with other therapies. About 300 adults wi…
Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC